Skip to main content

Two Sigma Advisers, LP

SEC CIK
0001478735
Latest filing
Aug 14, 2026

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Two Sigma Advisers, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overviewAll 13F holders of HZNPFull Q2 2026 holdings

Shares (Q4 2023)
0
Sold out in Q4 2023
Value
$0
% of portfolio
0.0%
Quarters held
8
Since Q1 2021
Holdings of HZNP by Two Sigma Advisers, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20230$00.0%−34,500−100.0%Sold outHolders
Q3 202334,500$3.99M<0.1%−291,600−89.4%ReducedHolders
Q2 2023326,100$33.5M0.1%+46,300+16.5%AddedHolders
Q1 2023279,800$30.5M0.1%+121,500+76.8%AddedHolders
Q4 2022158,300$18.0M0.1%−218,600−58.0%ReducedHolders
Q3 2022376,900$23.3M0.1%+364,400+2,915.2%AddedHolders
Q2 202212,500$997.0K<0.1%+12,500NewHolders
Q1 20220$00.0%−11,100−100.0%Sold outHolders
Q4 202111,100$1.20M<0.1%+11,100NewHolders
Q2 20210$00.0%−62,600−100.0%Sold outHolders
Q1 202162,600$5.76M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.